HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (Accepted Manuscript) All Versions of this Article: 279/5/3197    most recent C300520200v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wong, S. K. Articles by Farzan, M. Search for Related Content PubMed PubMed Citation Articles by Wong, S. K. Articles by Farzan, M. Social Bookmarking                      What's this?

Papers In Press, published online ahead of print December 11, 2003
J. Biol. Chem, 10.1074/jbc.C300520200
Submitted on December 2, 2003
Revised on December 11, 2003
Accepted on December 11, 2003

A 193-amino-acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

Department of Medicine, Harvard Medical School, Cambridge, MA 02139

Corresponding Author: farzan{at}mbcrr.harvard.edu

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Guillon, M. Clement, V. Sebille, J.-G. Rivain, C.-F. Chou, N. Ruvoen-Clouet, and J. Le Pendu Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies Glycobiology, December 1, 2008; 18(12): 1085 - 1093. [Abstract] [Full Text] [PDF]

				F. Li Structural Analysis of Major Species Barriers between Humans and Palm Civets for Severe Acute Respiratory Syndrome Coronavirus Infections J. Virol., July 15, 2008; 82(14): 6984 - 6991. [Abstract] [Full Text] [PDF]

				S. Haga, N. Yamamoto, C. Nakai-Murakami, Y. Osawa, K. Tokunaga, T. Sata, N. Yamamoto, T. Sasazuki, and Y. Ishizaka Modulation of TNF-{alpha}-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-{alpha} production and facilitates viral entry PNAS, June 3, 2008; 105(22): 7809 - 7814. [Abstract] [Full Text] [PDF]

				H.-X. Lin, Y. Feng, G. Wong, L. Wang, B. Li, X. Zhao, Y. Li, F. Smaill, and C. Zhang Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction J. Gen. Virol., April 1, 2008; 89(4): 1015 - 1024. [Abstract] [Full Text] [PDF]

				W. Ren, X. Qu, W. Li, Z. Han, M. Yu, P. Zhou, S.-Y. Zhang, L.-F. Wang, H. Deng, and Z. Shi Difference in Receptor Usage between Severe Acute Respiratory Syndrome (SARS) Coronavirus and SARS-Like Coronavirus of Bat Origin J. Virol., February 15, 2008; 82(4): 1899 - 1907. [Abstract] [Full Text] [PDF]

				R. L. Kaletsky, G. Simmons, and P. Bates Proteolysis of the Ebola Virus Glycoproteins Enhances Virus Binding and Infectivity J. Virol., December 15, 2007; 81(24): 13378 - 13384. [Abstract] [Full Text] [PDF]

				D. P. Han, M. Lohani, and M. W. Cho Specific Asparagine-Linked Glycosylation Sites Are Critical for DC-SIGN- and L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus Entry J. Virol., November 1, 2007; 81(21): 12029 - 12039. [Abstract] [Full Text] [PDF]

				V. C. C. Cheng, S. K. P. Lau, P. C. Y. Woo, and K. Y. Yuen Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection Clin. Microbiol. Rev., October 1, 2007; 20(4): 660 - 694. [Abstract] [Full Text] [PDF]

				S. Fukushi, T. Mizutani, K. Sakai, M. Saijo, F. Taguchi, M. Yokoyama, I. Kurane, and S. Morikawa Amino Acid Substitutions in the S2 Region Enhance Severe Acute Respiratory Syndrome Coronavirus Infectivity in Rat Angiotensin-Converting Enzyme 2-Expressing Cells J. Virol., October 1, 2007; 81(19): 10831 - 10834. [Abstract] [Full Text] [PDF]

				J. Zhao, W. Wang, W. Wang, Z. Zhao, Y. Zhang, P. Lv, F. Ren, and X.-M. Gao Comparison of Immunoglobulin G Responses to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients with SARS Clin. Vaccine Immunol., July 1, 2007; 14(7): 839 - 846. [Abstract] [Full Text] [PDF]

				K. Pyrc, B. Berkhout, and L. van der Hoek The Novel Human Coronaviruses NL63 and HKU1 J. Virol., April 1, 2007; 81(7): 3051 - 3057. [Full Text] [PDF]

				C. A. M. de Haan, E. te Lintelo, Z. Li, M. Raaben, T. Wurdinger, B. J. Bosch, and P. J. M. Rottier Cooperative Involvement of the S1 and S2 Subunits of the Murine Coronavirus Spike Protein in Receptor Binding and Extended Host Range J. Virol., November 15, 2006; 80(22): 10909 - 10918. [Abstract] [Full Text] [PDF]

				H. Hofmann, G. Simmons, A. J. Rennekamp, C. Chaipan, T. Gramberg, E. Heck, M. Geier, A. Wegele, A. Marzi, P. Bates, et al. Highly Conserved Regions within the Spike Proteins of Human Coronaviruses 229E and NL63 Determine Recognition of Their Respective Cellular Receptors. J. Virol., September 1, 2006; 80(17): 8639 - 8652. [Abstract] [Full Text] [PDF]

				M. Zhou, D. Xu, X. Li, H. Li, M. Shan, J. Tang, M. Wang, F.-S. Wang, X. Zhu, H. Tao, et al. Screening and Identification of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific CTL Epitopes J. Immunol., August 15, 2006; 177(4): 2138 - 2145. [Abstract] [Full Text] [PDF]

				F. Li, M. Berardi, W. Li, M. Farzan, P. R. Dormitzer, and S. C. Harrison Conformational States of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Ectodomain J. Virol., July 15, 2006; 80(14): 6794 - 6800. [Abstract] [Full Text] [PDF]

				J. H. Kuhn, S. R. Radoshitzky, A. C. Guth, K. L. Warfield, W. Li, M. J. Vincent, J. S. Towner, S. T. Nichol, S. Bavari, H. Choe, et al. Conserved Receptor-binding Domains of Lake Victoria Marburgvirus and Zaire Ebolavirus Bind a Common Receptor J. Biol. Chem., June 9, 2006; 281(23): 15951 - 15958. [Abstract] [Full Text] [PDF]

				P. Prabakaran, J. Gan, Y. Feng, Z. Zhu, V. Choudhry, X. Xiao, X. Ji, and D. S. Dimitrov Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody J. Biol. Chem., June 9, 2006; 281(23): 15829 - 15836. [Abstract] [Full Text] [PDF]

				Y. He, J. Li, S. Heck, S. Lustigman, and S. Jiang Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design. J. Virol., June 1, 2006; 80(12): 5757 - 5767. [Abstract] [Full Text] [PDF]

				Y. He, J. Li, W. Li, S. Lustigman, M. Farzan, and S. Jiang Cross-Neutralization of Human and Palm Civet Severe Acute Respiratory Syndrome Coronaviruses by Antibodies Targeting the Receptor-Binding Domain of Spike Protein J. Immunol., May 15, 2006; 176(10): 6085 - 6092. [Abstract] [Full Text] [PDF]

				J. Liu, H. Shao, Y. Tao, B. Yang, L. Qian, X. Yang, B. Cao, G. Hu, H. Tachibana, and X. Cheng Production of an Anti-Severe Acute Respiratory Syndrome (SARS) Coronavirus Human Monoclonal Antibody Fab Fragment by Using a Combinatorial Immunoglobulin Gene Library Derived from Patients Who Recovered from SARS. Clin. Vaccine Immunol., May 1, 2006; 13(5): 594 - 597. [Abstract] [Full Text] [PDF]

				W. Li, S.-K. Wong, F. Li, J. H. Kuhn, I-C. Huang, H. Choe, and M. Farzan Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus: Insight from ACE2-S-Protein Interactions J. Virol., May 1, 2006; 80(9): 4211 - 4219. [Full Text] [PDF]

				S C S Chow, C Y S Ho, T T Y Tam, C Wu, T Cheung, P K S Chan, M H L Ng, P K Hui, H K Ng, D M Y Au, et al. Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients J. Clin. Pathol., May 1, 2006; 59(5): 468 - 476. [Abstract] [Full Text] [PDF]

				D. Lavillette, R. Barbouche, Y. Yao, B. Boson, F.-L. Cosset, I. M. Jones, and E. Fenouillet Significant Redox Insensitivity of the Functions of the SARS-CoV Spike Glycoprotein: COMPARISON WITH HIV ENVELOPE J. Biol. Chem., April 7, 2006; 281(14): 9200 - 9204. [Abstract] [Full Text] [PDF]

				W.-E. Chan, C.-K. Chuang, S.-H. Yeh, M.-S. Chang, and S. S.-L. Chen Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus. J. Virol., April 1, 2006; 80(7): 3225 - 3237. [Abstract] [Full Text] [PDF]

				J.-S. Lee, H. Poo, D. P. Han, S.-P. Hong, K. Kim, M. W. Cho, E. Kim, M.-H. Sung, and C.-J. Kim Mucosal Immunization with Surface-Displayed Severe Acute Respiratory Syndrome Coronavirus Spike Protein on Lactobacillus casei Induces Neutralizing Antibodies in Mice. J. Virol., April 1, 2006; 80(8): 4079 - 4087. [Abstract] [Full Text] [PDF]

				R. H. See, A. N. Zakhartchouk, M. Petric, D. J. Lawrence, C. P. Y. Mok, R. J. Hogan, T. Rowe, L. A. Zitzow, K. P. Karunakaran, M. M. Hitt, et al. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. J. Gen. Virol., March 1, 2006; 87(Pt 3): 641 - 650. [Abstract] [Full Text] [PDF]

				I-C. Huang, B. J. Bosch, F. Li, W. Li, K. H. Lee, S. Ghiran, N. Vasilieva, T. S. Dermody, S. C. Harrison, P. R. Dormitzer, et al. SARS Coronavirus, but Not Human Coronavirus NL63, Utilizes Cathepsin L to Infect ACE2-expressing Cells J. Biol. Chem., February 10, 2006; 281(6): 3198 - 3203. [Abstract] [Full Text] [PDF]

				R. Broer, B. Boson, W. Spaan, F.-L. Cosset, and J. Corver Important Role for the Transmembrane Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein during Entry J. Virol., February 1, 2006; 80(3): 1302 - 1310. [Abstract] [Full Text] [PDF]

				K.-M. Lip, S. Shen, X. Yang, C.-T. Keng, A. Zhang, H.-L. J. Oh, Z.-H. Li, L.-A. Hwang, C.-F. Chou, B. C. Fielding, et al. Monoclonal Antibodies Targeting the HR2 Domain and the Region Immediately Upstream of the HR2 of the S Protein Neutralize In Vitro Infection of Severe Acute Respiratory Syndrome Coronavirus J. Virol., January 15, 2006; 80(2): 941 - 950. [Abstract] [Full Text] [PDF]

				S. R. Weiss and S. Navas-Martin Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus Microbiol. Mol. Biol. Rev., December 1, 2005; 69(4): 635 - 664. [Abstract] [Full Text] [PDF]

				C. A. M. de Haan, Z. Li, E. te Lintelo, B. J. Bosch, B. J. Haijema, and P. J. M. Rottier Murine Coronavirus with an Extended Host Range Uses Heparan Sulfate as an Entry Receptor J. Virol., November 15, 2005; 79(22): 14451 - 14456. [Abstract] [Full Text] [PDF]

				S. K. P. Lau, P. C. Y. Woo, K. S. M. Li, Y. Huang, H.-W. Tsoi, B. H. L. Wong, S. S. Y. Wong, S.-Y. Leung, K.-H. Chan, and K.-Y. Yuen Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats PNAS, September 27, 2005; 102(39): 14040 - 14045. [Abstract] [Full Text] [PDF]

				F. Li, W. Li, M. Farzan, and S. C. Harrison Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor Science, September 16, 2005; 309(5742): 1864 - 1868. [Abstract] [Full Text] [PDF]

				C. E. Yi, L. Ba, L. Zhang, D. D. Ho, and Z. Chen Single Amino Acid Substitutions in the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Determine Viral Entry and Immunogenicity of a Major Neutralizing Domain J. Virol., September 15, 2005; 79(18): 11638 - 11646. [Abstract] [Full Text] [PDF]

				X.-X. Qu, P. Hao, X.-J. Song, S.-M. Jiang, Y.-X. Liu, P.-G. Wang, X. Rao, H.-D. Song, S.-Y. Wang, Y. Zuo, et al. Identification of Two Critical Amino Acid Residues of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Its Variation in Zoonotic Tropism Transition via a Double Substitution Strategy J. Biol. Chem., August 19, 2005; 280(33): 29588 - 29595. [Abstract] [Full Text] [PDF]

				N. Pogrebnyak, M. Golovkin, V. Andrianov, S. Spitsin, Y. Smirnov, R. Egolf, and H. Koprowski Severe acute respiratory syndrome (SARS) S protein production in plants: Development of recombinant vaccine PNAS, June 21, 2005; 102(25): 9062 - 9067. [Abstract] [Full Text] [PDF]

				I-M. Yu, C. L. T. Gustafson, J. Diao, J. W. Burgner II, Z. Li, J. Zhang, and J. Chen Recombinant Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein Forms a Dimer through Its C-terminal Domain J. Biol. Chem., June 17, 2005; 280(24): 23280 - 23286. [Abstract] [Full Text] [PDF]

				B. Sainz Jr., J. M. Rausch, W. R. Gallaher, R. F. Garry, and W. C. Wimley Identification and Characterization of the Putative Fusion Peptide of the Severe Acute Respiratory Syndrome-Associated Coronavirus Spike Protein J. Virol., June 1, 2005; 79(11): 7195 - 7206. [Abstract] [Full Text] [PDF]

				H. Hofmann, K. Pyrc, L. van der Hoek, M. Geier, B. Berkhout, and S. Pohlmann Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry PNAS, May 31, 2005; 102(22): 7988 - 7993. [Abstract] [Full Text] [PDF]

				J. Sui, W. Li, A. Roberts, L. J. Matthews, A. Murakami, L. Vogel, S. K. Wong, K. Subbarao, M. Farzan, and W. A. Marasco Evaluation of Human Monoclonal Antibody 80R for Immunoprophylaxis of Severe Acute Respiratory Syndrome by an Animal Study, Epitope Mapping, and Analysis of Spike Variants J. Virol., May 15, 2005; 79(10): 5900 - 5906. [Abstract] [Full Text] [PDF]

				B. Nal, C. Chan, F. Kien, L. Siu, J. Tse, K. Chu, J. Kam, I. Staropoli, B. Crescenzo-Chaigne, N. Escriou, et al. Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E J. Gen. Virol., May 1, 2005; 86(5): 1423 - 1434. [Abstract] [Full Text] [PDF]

				Y. He, H. Lu, P. Siddiqui, Y. Zhou, and S. Jiang Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies J. Immunol., April 15, 2005; 174(8): 4908 - 4915. [Abstract] [Full Text] [PDF]

				C.-T. Keng, A. Zhang, S. Shen, K.-M. Lip, B. C. Fielding, T. H. P. Tan, C.-F. Chou, C. B. Loh, S. Wang, J. Fu, et al. Amino Acids 1055 to 1192 in the S2 Region of Severe Acute Respiratory Syndrome Coronavirus S Protein Induce Neutralizing Antibodies: Implications for the Development of Vaccines and Antiviral Agents J. Virol., March 15, 2005; 79(6): 3289 - 3296. [Abstract] [Full Text] [PDF]

				Z. Chen, L. Zhang, C. Qin, L. Ba, C. E. Yi, F. Zhang, Q. Wei, T. He, W. Yu, J. Yu, et al. Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding Region J. Virol., March 1, 2005; 79(5): 2678 - 2688. [Abstract] [Full Text] [PDF]

				H.-D. Song, C.-C. Tu, G.-W. Zhang, S.-Y. Wang, K. Zheng, L.-C. Lei, Q.-X. Chen, Y.-W. Gao, H.-Q. Zhou, H. Xiang, et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human PNAS, February 15, 2005; 102(7): 2430 - 2435. [Abstract] [Full Text] [PDF]

				E. N. van den Brink, J. ter Meulen, F. Cox, M. A. C. Jongeneelen, A. Thijsse, M. Throsby, W. E. Marissen, P. M. L. Rood, A. B. H. Bakker, H. R. Gelderblom, et al. Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus J. Virol., February 1, 2005; 79(3): 1635 - 1644. [Abstract] [Full Text] [PDF]

				S. Wang, T.-h. W. Chou, P. V. Sakhatskyy, S. Huang, J. M. Lawrence, H. Cao, X. Huang, and S. Lu Identification of Two Neutralizing Regions on the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Produced from the Mammalian Expression System J. Virol., February 1, 2005; 79(3): 1906 - 1910. [Abstract] [Full Text] [PDF]

				Z.-y. Yang, H. C. Werner, W.-p. Kong, K. Leung, E. Traggiai, A. Lanzavecchia, and G. J. Nabel Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses PNAS, January 18, 2005; 102(3): 797 - 801. [Abstract] [Full Text] [PDF]

				Y.-J. Chang, C. Y.-Y. Liu, B.-L. Chiang, Y.-C. Chao, and C.-C. Chen Induction of IL-8 Release in Lung Cells via Activator Protein-1 by Recombinant Baculovirus Displaying Severe Acute Respiratory Syndrome-Coronavirus Spike Proteins: Identification of Two Functional Regions J. Immunol., December 15, 2004; 173(12): 7602 - 7614. [Abstract] [Full Text] [PDF]

				M. J. Huentelman, J. Zubcevic, J. A. Hernandez Prada, X. Xiao, D. S. Dimitrov, M. K. Raizada, and D. A. Ostrov Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor Hypertension, December 1, 2004; 44(6): 903 - 906. [Abstract] [Full Text] [PDF]

				H. C. Song, M.-Y. Seo, K. Stadler, B. J. Yoo, Q.-L. Choo, S. R. Coates, Y. Uematsu, T. Harada, C. E. Greer, J. M. Polo, et al. Synthesis and Characterization of a Native, Oligomeric Form of Recombinant Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein J. Virol., October 1, 2004; 78(19): 10328 - 10335. [Abstract] [Full Text] [PDF]

				Y. He, Y. Zhou, H. Wu, B. Luo, J. Chen, W. Li, and S. Jiang Identification of Immunodominant Sites on the Spike Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Implication for Developing SARS Diagnostics and Vaccines J. Immunol., September 15, 2004; 173(6): 4050 - 4057. [Abstract] [Full Text] [PDF]

				R. W.K. Chiu, N. L.S. Tang, D. S.C. Hui, G. T.Y. Chung, S. S.C. Chim, K.C. A. Chan, Y.-m. Sung, L. Y.S. Chan, Y.-k. Tong, W.-s. Lee, et al. ACE2 Gene Polymorphisms Do Not Affect Outcome of Severe Acute Respiratory Syndrome Clin. Chem., September 1, 2004; 50(9): 1683 - 1686. [Full Text] [PDF]

				T. Zhou, H. Wang, D. Luo, T. Rowe, Z. Wang, R. J. Hogan, S. Qiu, R. J. Bunzel, G. Huang, V. Mishra, et al. An Exposed Domain in the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Induces Neutralizing Antibodies J. Virol., July 1, 2004; 78(13): 7217 - 7226. [Abstract] [Full Text] [PDF]